Showing results 1 to 1 of 1
Title | Author(s) | Issue Date | |
---|---|---|---|
Responses to peginterferon alfa-2a (40KD) (PEGASYS) treatment are durable in Asian Patients with HBeAg-Negative CHB: 12 month Follow-Up Data from a large Randomised Study Proceeding/Conference:Journal of Gastroenterology and Hepatology | 2006 |